Short answer
GE HealthCare (GEHC) filed an 8-K current report with the SEC on October 28, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). GE HealthCare announced third-quarter 2026 financial results on October 28, 2026.
GE HealthCare 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- GE HealthCare announced third-quarter 2026 financial results on October 28, 2026
- Detailed results, guidance, and management commentary are contained in Exhibit 99 press release
Item 5.02 · Departure/Election of Directors or Officers
- Jeannette Bankes resigning as President and CEO, Patient Care Solutions
- Departure effective November 15, 2026
- Leadership transition creates execution risk for GE HealthCare’s Patient Care Solutions segment
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $5.5B, up 7.2%, with organic growth 6.2% across all segments
- Adjusted EBIT margin 16.6%, up 180 bps, while adjusted EPS rose 25.1% to $1.34
- Orders grew organically 4.0%, book-to-bill 1.03x, and backlog reached $23.7B, supporting forward demand visibility
- Full-year guidance raised: organic growth ~4.0%, adjusted EPS $4.95-$5.05, free cash flow $1.6B+
- Planned $945M cash SOFIE Biosciences acquisition, expected to close in first half of 2027, expands U.S. PET radiopharmaceutical distribution
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other GE HealthCare 8-K filings
Get the next GEHC 8-K as it lands
Follow GEHC for push alerts, or ask the research agent what this filing means.